These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2269011)

  • 1. Update: prostate cancer.
    Fukuda CS; Brawer MK
    Compr Ther; 1990 Nov; 16(11):15-25. PubMed ID: 2269011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenocarcinoma of the prostate.
    Swanson JO
    J Insur Med; 1997; 29(3):195-203. PubMed ID: 10176369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.
    Harlan SR; Cooperberg MR; Elkin E; Lubeck DP; Meng M; Mehta SS; Carroll PR
    J Urol; 2003 Nov; 170(5):1804-7. PubMed ID: 14532780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer diagnosed in spinal cord-injured patients is more commonly advanced stage than in able-bodied patients.
    Scott PA; Perkash I; Mode D; Wolfe VA; Terris MK
    Urology; 2004 Mar; 63(3):509-12. PubMed ID: 15028447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
    Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
    Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, diagnosis and treatment of prostate cancer.
    Newman J
    Radiol Technol; 1996; 68(1):39-64; quiz 65-8. PubMed ID: 8880970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adenocarcinoma of the prostate].
    Dvorácek J
    Cas Lek Cesk; 1998 Aug; 137(17):515-21. PubMed ID: 9787503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM; Porter MP; Soloway MS
    J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidence and epidemiology of prostatic cancer in the Urology Department at CHU-Tokoin (Lome-Togo)].
    Anoukoum T; Attipou KK; Napo-Kaoura AG; Ayite A; Safwat Y; James K
    Tunis Med; 1998 Feb; 76(2):1061-4. PubMed ID: 9844543
    [No Abstract]   [Full Text] [Related]  

  • 10. The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment.
    Mettlin CJ; Murphy GP; Cunningham MP; Menck HR
    Cancer; 1997 Oct; 80(7):1261-6. PubMed ID: 9317177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of obstructive uropathy in advanced prostate cancer.
    Oefelein MG
    Urology; 2004 Jun; 63(6):1117-21. PubMed ID: 15183963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prostatic adenocarcinoma. I. History of its treatment and study of its prognostic factors. Review of the literature].
    Valls Fontanals A; Panadés Nigorra G; Ballester Moll T
    Actas Urol Esp; 1985; 9(2):109-14. PubMed ID: 3893052
    [No Abstract]   [Full Text] [Related]  

  • 13. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
    Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
    Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.
    Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO
    J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in quality of care for men with early-stage prostate cancer.
    Spencer BA; Miller DC; Litwin MS; Ritchey JD; Stewart AK; Dunn RL; Gay EG; Sandler HM; Wei JT
    J Clin Oncol; 2008 Aug; 26(22):3735-42. PubMed ID: 18669460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.
    Davison BJ; Oliffe JL; Pickles T; Mroz L
    Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical retropubic prostatectomy in men younger than 45 years diagnosed during early prostate cancer detection program.
    Varkarakis J; Pinggera GM; Sebe P; Berger A; Bartsch G; Horninger W
    Urology; 2004 Feb; 63(2):337-41. PubMed ID: 14972485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical analysis of 169 patients with prostate cancer].
    Okaneya T; Mizusawa H; Yoneyama T; Taguchi I; Komiyama I; Kawakami M; Hosaka K; Tsuruta T; Murata Y; Komatsu H; Misawa K; Kiyokawa H
    Hinyokika Kiyo; 1996 Aug; 42(8):563-7. PubMed ID: 8889563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis based on prostate needle biopsy: inadequate correlation between pathologic results and clinical course for individual prognosis].
    van der Kwast TH; Hoedemaeker RF; Schröder FH
    Ned Tijdschr Geneeskd; 2005 Apr; 149(18):972-6. PubMed ID: 15903037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.